472 related articles for article (PubMed ID: 18423640)
41. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression.
Luscombe C; Pedersen J; Uren E; Locarnini S
Hepatology; 1996 Oct; 24(4):766-73. PubMed ID: 8855174
[TBL] [Abstract][Full Text] [Related]
42. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
43. Effect of cantharidin, cephalotaxine and homoharringtonine on "in vitro" models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication.
Romero MR; Serrano MA; Efferth T; Alvarez M; Marin JJ
Planta Med; 2007 Jun; 73(6):552-8. PubMed ID: 17458779
[TBL] [Abstract][Full Text] [Related]
44. Anti-hepatitis B virus activity of α-DDB-DU, a novel nucleoside analogue, in vitro and in vivo.
Zheng LY; Zang LM; Yang QH; Yu WQ; Fang XZ; Zhang YH; Zhao XJ; Wan N; Zhang YT; Wang QD; Chang JB
Eur J Pharmacol; 2013 Feb; 702(1-3):258-63. PubMed ID: 23415746
[TBL] [Abstract][Full Text] [Related]
45. [Effect of ampelopsis of Ampelopsis grossedentata on duck hepatitis B virus].
Yan L; Zheng Z
Zhongguo Zhong Yao Za Zhi; 2009 Apr; 34(7):908-10. PubMed ID: 19623994
[TBL] [Abstract][Full Text] [Related]
46. [Experimental study on anti-DHBV effect of yu gan capsules].
Tan X; Zhang A; Yu W; Cen Y; Zhang F
Zhong Yao Cai; 2005 Aug; 28(8):679-81. PubMed ID: 16379421
[TBL] [Abstract][Full Text] [Related]
47. Involvement of GRP78 in inhibition of HBV secretion by Boehmeria nivea extract in human HepG2 2.2.15 cells.
Huang KL; Lai YK; Lin CC; Chang JM
J Viral Hepat; 2009 May; 16(5):367-75. PubMed ID: 19228285
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
49. [Screening of antiviral agents from medicinal herbs by means of Hepadnaviruses models].
Mi Z; Chen H; Zhang X; Li Z; Chen W; Shao X
Zhongguo Zhong Yao Za Zhi; 1997 Jan; 22(1):43-5, 63. PubMed ID: 10683913
[TBL] [Abstract][Full Text] [Related]
50. [The inhibitory effect of compound liuyuexue on DHBV DNA].
Zhang SJ; Lin J; Jiang WZ; Huang CX; Huamg RB
Zhong Yao Cai; 2007 Feb; 30(2):191-3. PubMed ID: 17571772
[TBL] [Abstract][Full Text] [Related]
51. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
Miller DS; Kotlarski I; Jilbert AR
Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
[TBL] [Abstract][Full Text] [Related]
52. Anti-hepatitis B virus activities of Geranium carolinianum L. extracts and identification of the active components.
Li J; Huang H; Zhou W; Feng M; Zhou P
Biol Pharm Bull; 2008 Apr; 31(4):743-7. PubMed ID: 18379075
[TBL] [Abstract][Full Text] [Related]
53. A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes.
Shin MS; Kang EH; Lee YI
Antiviral Res; 2005 Sep; 67(3):163-8. PubMed ID: 16118024
[TBL] [Abstract][Full Text] [Related]
54. [Replication and transfection of hepatitis B virus DNA into primary duck hepatocytes].
Yao Y; Huang A; Tang N; Wang B; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):34-6. PubMed ID: 11856500
[TBL] [Abstract][Full Text] [Related]
55. EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs.
Xuan B; Qian Z; Hong J; Huang W
Virus Res; 2006 Jun; 118(1-2):150-5. PubMed ID: 16423421
[TBL] [Abstract][Full Text] [Related]
56. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
[TBL] [Abstract][Full Text] [Related]
57. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.
Foster WK; Miller DS; Scougall CA; Kotlarski I; Colonno RJ; Jilbert AR
J Virol; 2005 May; 79(9):5819-32. PubMed ID: 15827196
[TBL] [Abstract][Full Text] [Related]
58. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
59. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
Zoulim F; Dannaoui E; Borel C; Hantz O; Lin TS; Liu SH; Trépo C; Cheng YC
Antimicrob Agents Chemother; 1996 Feb; 40(2):448-53. PubMed ID: 8834896
[TBL] [Abstract][Full Text] [Related]
60. [Ultrastructural study and localization of duck hepatitis B virus in the livers of experimentally infected ducks].
Tian P
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Apr; 13(2):108-11. PubMed ID: 1831706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]